Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database.
Yosuke MatsuuraMingon MunYasushi ShintaniJiro OkamiHiroyuki ItoTakashi OhtsukaTakeshi MoriShun-Ichi WatanabeMasayuki ChidaShunsuke EndoRyoichi NakanishiMitsutaka KadokuraHidemi SuzukiEtsuo MiyaokaIchiro YoshinoHiroshi Datenull nullPublished in: Journal of surgical oncology (2023)
In one of the largest national surveys, ALK rearrangement was associated with improved long-term outcomes in surgically resected patients. ALK-TKIs may be an important treatment strategy for ALK rearrangement-positive lung adenocarcinoma in the postrecurrence state.
Keyphrases
- early stage
- advanced non small cell lung cancer
- end stage renal disease
- prognostic factors
- newly diagnosed
- cross sectional
- lymph node
- diffuse large b cell lymphoma
- squamous cell carcinoma
- emergency department
- patient reported outcomes
- combination therapy
- tyrosine kinase
- epidermal growth factor receptor
- sentinel lymph node
- rectal cancer